Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL9632138

ClCCl.ClCCl.ClCCl.O=C(O)C(F)(F)F

nearest known ligand 0.41

Full drug profile on Sugi Atlas →

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.41
TSHR P16473 3/20 0.41
TP53 P04637 1/20 0.41
L3MBTL1 Q9Y468 1/20 0.36
ACLY P53396 2/20 0.36
THRB P10828 1/20 0.35
CES1 P23141 2/20 0.33
POLB P06746 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
CA2 P00918 1/20 0.33
TET2 Q6N021 1/20 0.32
MEN1 O00255 1/20 0.32
KMT2A Q03164 1/20 0.32
FAAH O00519 1/20 0.31
HRH4 Q9H3N8 1/20 0.31
HRH3 Q9Y5N1 1/20 0.31
NOS1 P29475 1/20 0.31
NOS2 P35228 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Trifluoroacetic Acid SCHEMBL1525100 1.00 ALDH1A1 (0.41) ALDH1A1TSHRTP53L3MBTL1ACLY
Trifluoroacetic Acid SCHEMBL4163974 1.00 ALDH1A1 (0.41) ALDH1A1TSHRTP53L3MBTL1ACLY
Trifluoroacetic Acid SCHEMBL4809831 1.00 ALDH1A1 (0.41) ALDH1A1TSHRTP53L3MBTL1ACLY
Trifluoroacetic Acid SCHEMBL19552090 1.00 ALDH1A1 (0.41) ALDH1A1TSHRTP53L3MBTL1ACLY
Trifluoroacetic Acid SCHEMBL3634014 1.00 ALDH1A1 (0.41) ALDH1A1TSHRTP53L3MBTL1ACLY
Trifluoroacetic Acid SCHEMBL60574 1.00 ALDH1A1 (0.41) ALDH1A1TSHRTP53L3MBTL1ACLY
Trifluoroacetic Acid SCHEMBL19552101 1.00 ALDH1A1 (0.41) ALDH1A1TSHRTP53L3MBTL1ACLY
Trifluoroacetic Acid SCHEMBL996801 0.97 ALDH1A1 (0.39) ALDH1A1TSHRTP53L3MBTL1ACLY
Trifluoroacetic Acid SCHEMBL11086962 0.97 ALDH1A1 (0.39) ALDH1A1TSHRTP53L3MBTL1ACLY
Trifluoroacetic Acid SCHEMBL4872786 0.94 TSHR (0.37) ALDH1A1TSHRTP53L3MBTL1ACLY

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024125642-A1 PYRIMIDINE-CONTAINING POLYCYCLIC DERIVATIVE INHIBITOR, AND PREPARATION METHOD THEREFOR AND USE THEREOF 上海翰森生物医药科技有限公司 2024-06-20 WO disclosed
CN-115260211-B Thiophene condensed ring derivative, pharmaceutical composition, preparation method and application thereof 长春金赛药业有限责任公司 2024-02-06 CN disclosed
WO-2023227118-A1 3C-LIKE PROTEASE INHIBITOR 广州国家实验室 2023-11-30 WO disclosed
CN-115260211-A Thiophene fused ring containing derivative, pharmaceutical composition, preparation method and application thereof 长春金赛药业有限责任公司 2022-11-01 CN disclosed
US-10294199-B2 Propyl cationic peptide lipids, synthesis method thereof, and application thereof DALIAN NATIONALITIES UNIVERSITY (CN) 2019-05-21 US disclosed
US-20170355667-A1 PROPYL CATIONIC PEPTIDE LIPIDS, SYNTHESIS METHOD THEREOF, AND APPLICATION THEREOF DALIAN NATIONALITIES UNIVERSITY (CN) 2017-12-14 US disclosed
US-5089500-A Viricides; hepatitis, aids BURROUGHS WELLCOME CO. (US) 1992-02-18 US disclosed
US-5034394-A Therapeutic nucleosides BURROUGHS WELLCOME CO. (US) 1991-07-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170355667-A1 PROPYL CATIONIC PEPTIDE LIPIDS, SYNTHESIS METHOD THEREOF, AND APPLICATION THEREOF PCNP, PLIN1, PLIN3 ALDH1A1 4655/4885TSHR 1252/4885TP53 2534/4885
US-10294199-B2 Propyl cationic peptide lipids, synthesis method thereof, and application thereof PCNP, PLIN1, PLIN3 ALDH1A1 4655/4885TSHR 1252/4885TP53 2534/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.